ABOUT SYNTHEGO
Synthego is a genome engineering company that enables life science research and therapy development with a mission of increased access to engineered therapies for all patients. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports CRISPR-edited cell and gene therapeutic development at every step, from R&D through IND submission to first-in-human trials.
FEATURED CONTENT
-
![Guidance-Puzzle-Regulatory-iStock-489087670]( "CMC And Regulatory Considerations For CRISPR Therapies")
This article explores the details of Chemistry, Manufacturing, and Controls and Critical Quality Attributes, which play an important role in gene editing.
-
![GettyImages-1366661187 cell tech]( "CRISPR Clinical Trials To Follow In 2024 And Beyond")
CRISPR therapies are being developed for genetic disorders, cancer, and infectious diseases. Explore which CRISPR clinical trials are worth keeping an eye on this year.
-
![Crispr gene editing-GettyImages-1139760176]( "CRISPR 101 - Your Guide To Understanding CRISPR")
Review the fundamentals of CRISPR technology, development, and its use to manipulate genes in different ways, such as altering their nucleotide sequences or changing their expression.
-
![CRISPR Gene Editing]( "CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs")
Navigate the intricate regulatory landscape with knowledge that can help you move your CRISPR therapies quickly and efficiently through clinical trials.
-
![GettyImages-1445640967 RNA therapy]( "CRISPR In The Clinic: Regulatory Experts Discuss Development Of Cell And Gene Therapies")
A regulatory expert provides her insight on what regulatory experts do and how they can help you accelerate your path from bench to clinic.
-
![Laboratory-Mouse-GettyImages-172267826]( "Advances In CRISPR Disease Modeling")
Disease modeling helps us understand disease and create therapies. Learn about the types of disease models, the impact of CRISPR, current challenges, and trends.
-
![Synthego sgrna bucket]( "CRISPR sgRNA For Successful Gene Editing: Discovery To Clinic")
The single guide RNA (sgRNA) is one of the key components of successful CRISPR gene editing. Here we cover all the important aspects of sgRNA and Synthego’s sgRNA products.
-
![FDA-Approved-GettyImages-1186545957]( "Regulatory Trends In Cell And Gene Therapies")
Join a discussion surrounding cell and gene therapy products, specific FDA initiatives, broader regulatory trends, and the predicted growth of cell and gene therapy products in the coming years.
-
![iStock-696241690-cell-gene]( "Rapid Rise And Promising Future Of CRISPR Cell And Gene Therapies")
What is cell and gene therapy and how has the invention of CRISPR revolutionized the industry? Learn about the history of these therapies and life-changing treatments on the horizon.
-
![GettyImages- 1180547354 trial data]( "Understanding CRISPR Clinical Trials: Your Questions Answered")
CRISPR technology is revolutionizing cell and gene therapies, but how do CRISPR clinical trials work? Follow this explanation of CRISPR therapies from the discovery phase to FDA approval.
-
![Gene Therapy iStock-1291142726]( "Key Challenges for CRISPR In Clinical Development")
Learn how to approach CRISPR cell and gene therapy development challenges, such as regulatory hurdles, ensuring consistency, finding qualified and experienced staff, and obtaining GMP-Grade reagents.
-
![GettyImages-958260280-genetic-engineering-genome-editing-helix-dna]( "Understanding FDA Cell And Gene Therapy Guidance")
Grow your understanding of how new developments in CRISPR gene therapy drugs and FDA guidance are affecting cell and gene therapy products.
VIDEOS
-
![synthego testimonial feature]( "Groundbreaking Casgevy Approval Retrospective")
How is the approval of the US' first CRISPR therapy reshaping the landscape of CRISPR regulations and ongoing clinical trials?
-
![CRISPR research-GettyImages-959053706]( "Casgevy Approval Retrospective With Lina Jamis")
In this insightful video, Lina Jamis, Associate Director of Regulatory Affairs at Synthego, shares key learnings and valuable perspectives on the latest developments in the field of CRISPR therapeutics.
-
![GettyImages-879828000-lab-cell-microscope]( "Discovery To Clinic: CRISPR-Based Therapies And Diagnostics")
As CRISPR use continues to grow, so has the demand for clinical-grade guide RNA. Learn about GMP sgRNA and their stringent process and manufacturing controls.
-
![Gene therapy iStock-1177162185]( "Moving CRISPR Therapies From Research To The Clinic")
Professor Stephanie Cherqui shares her thoughts on taking CRISPR-based therapies from research to the clinic, the upcoming trials she is working on, and more.
-
![synthego suites]( "Next Generation GMP Facility For CRISPR Based Therapies")
Explore a state-of-the-art GMP facility focused on CRISPR based Cell and Gene therapies with helping temperature controlled warehouse and multiple synthesis suites.
-
![Cell and Gene genetic lab Getty Images-1209892070]( "Forge A Successful CRISPR Therapeutic Path With High-Quality GMP sgRNA")
Learn how to accelerate your clinical timeline for cell and gene therapies and improve next-generation GMP production facilities.
-
![facility diagram]( "First Look At A Next-Generation GMP Facility")
Explore this video explaining a next-generation GMP sgRNA facility.
-
![GettyImages-1351646522 clinical trials]( "A CRISPR Clinical Trial Patient Discusses His Sickle Cell Journey")
Learn about the clinical trial for a new sickle cell disease treatment from an early clinical trial patient who has, at this time, experienced complete recovery from symptoms.
CONTACT INFORMATION
Synthego Corporation
3696 Haven Ave, Suite A
Redwood City, CA 94063
UNITED STATES
Phone: 888-622-6883
Contact: Meenakshi Prabhune
FEATURED PRODUCTS
-
![Guidance-Puzzle-Regulatory-iStock-489087670]( "CRISPR Therapeutic Regulatory Expertise And Support")
Explore regulatory support services that can help you successfully to navigate CRISPR-based therapeutic development and prepare you for a successful IND submission.
-
![GettyImages-1294339662-lab-cleanroom-computer]( "GMP sgRNA Manufacturing")
Transition from early-phase research through process development into the clinic with these continuum sgRNA available in different grades.
-
![3 Cleanroom Scientists GettyImages-1301319238]( "INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies")
Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.
-
![Synthego synthetic sgRNA]( "Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments")
Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.
-
![GettyImages-1386852216 cell therapy]( "INDe sgRNA Manufacturing")
Move your CRISPR-based therapeutics from discovery to delivery in a seamless transition with IND-enabling (INDe) sgRNAs designed specifically for preclinical safety, toxicity, and efficacy studies.
-
![GettyImages-1356994684-epigenetics-rna]( "High-Quality sgRNAs For Your CRISPR Therapy Products")
IND-enabling sgRNAs are high quality sgRNAs with increased quality oversight and documentation enabling comparability between reagents as you transition into clinical trials.
-
![Synthego facility]( "New Next-Generation GMP Facility")
A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.
-
![Partners-Getty- 871491468]( "High Quality Clinical Grade sgRNA For CRISPR Based Therapies")
Learn about three different grades of high-quality synthetic sgRNAs that will help support every step of your CRISPR-based therapy development process.
